Cutting edge: Low-affinity, Smith antigen-specific B cells are tolerized by dendritic cells and macrophages

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 37-41

  Kilmon, Michelle A ^a   Rutan, Jennifer A ^a   Clarke, Stephen H ^a   Vilen, Barbara J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AZOBENZENEARSONIC ACID; B LYMPHOCYTE ANTIGEN; INTERLEUKIN 6; LYSOZYME; SMITH ANTIGEN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; AUTOANTIGEN; SM NUCLEAR ANTIGENS; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BINDING AFFINITY; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; A J MOUSE; ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; DENDRITIC CELLS; IMMUNE TOLERANCE; IMMUNITY, NATURAL; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED A; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MURAMIDASE; RIBONUCLEOPROTEINS, SMALL NUCLEAR;

EID: 21244498502     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.37     Document Type: Article

References (19)

1. Rui, L., C. G. Vinuesa, J. Blasioli, and C. C. Goodnow. 2003. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol. 4: 594-600.
2. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
3. Tomioka, H., H. Saito, and K. Sato. 1990. Characteristics of immunosuppressive macrophages induced in host spleen cells by Mycobacterium avium complex and Mycobacterium tuberculosis infections in mice. Microbiol. Immunol. 34: 283-297.
4. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
5. Jego, G., A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234.
6. Balazs, M., F. Martin, T. Zhou, and J. Kearney. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17: 341-352.
7. Craxton, A., D. Magaletti, E. J. Ryan, and E. A. Clark. 2003. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471.
8. Borrero, M., and S. H. Clarke. 2002. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J. Immunol. 168: 13-21.
9. Benschop, R. J., K. Aviszus, X. Zhang, T. Manser, J. C. Cambier, and L. J. Wysocki. 2001. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity 14: 33-43.
10. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, and K. Raphael. 1988. Altered immunoglobulin expression and functional silencing of self- reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
11. Inaoki, M., S. Sato, B. C. Weintraub, C. C. Goodnow, and T. F. Tedder. 1997. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186: 1923-1931.
12. Muraguchi, A., T. Hirano, B. Tang, T. Matsuda, Y. Horii, K. Nakajima, and T. Kishimoto. 1988. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167: 332-344.
13. Qian, Y., H. Wang, and S. H. Clarke. 2004. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J. Immunol. 172: 625-635.
14. Santulli-Marotto, S., M. W. Retter, R. Gee, M. J. Mamula, and S. H. Clarke. 1998. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8: 209-219.
15. Grant, S. L., A. Hammacher, A. M. Douglas, G. A. Goss, R. K. Mansfield, J. K. Heath, and C. G. Begley. 2002. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Oncogene 21: 460-474.
16. Mitani, Y., A. Takaoka, S. H. Kim, Y. Kato, T. Yokochi, N. Tanaka, and T. Taniguchi. 2001. Cross-talk of the interferon α/β signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells 6: 631-640.
17. 1 hybrid. Clin. Immunol. Immunopathol. 62: 264-269.
18. Davas, E. M., A. Tsirogianni, I. Kappou, D. Karamitsos, I. Economidou, and P. C. Dantis. 1999. Serum IL-6, TNFα, p55 srTNFα, p75srTNFα, srIL-2α levels and disease activity in systemic lupus erythematosus. Clin. Rheumatol. 18: 17-22.
19. Neng, L. K., J. C. Leung, L. K. Bik, P. K. Li, and C. K. Lai. 1996. Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from endothelial cells. J. Pathol. 178: 451-457.